Giuliani S.p.A acquires majority stake in MIKA Pharma GmbH

25-Mar-2010 - Germany

MIKA Pharma GmbH announced that Giuliani S.p.A, a Milano, Italy based Pharma company has acquired a majority stake in MIKA Pharma.

Based on its proprietary nanoemulsion drug delivery technology, MIKA Pharma has developed a wide range of topical products including Diclofenac Spray, Ketoprofen Spray, and Heparin Spray. All of these products were successfully developed by MIKA Pharma and are currently registered in 32 countries. MIKA Pharma has granted licensing rights to a variety of partners to commercialise these products. In addition MIKA Pharma is developing a broad clinical pipeline of topical products for the treatment of pain and inflammation.

Bernd Seigfried, CEO of MIKA comments: "Giuliani S.p.A is the preferred strategic partner to further develop our international clinical projects. At the same time we already have products in commercial stage, here as well Giuliani S.p.A will help to faster exploit the various market opportunities."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances